For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...
"Muscle Invasive Bladder Cancer Competitive Landscape"Muscle Invasive Bladder Cancer companies are Merck Sharp & Dohme LLC, Aura Biosciences, Janssen Research & Development, LLC, Asieris ...
Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...
NEW YORK, June 6 (Reuters) - One of the most common problems in the United States -- an overactive bladder -- is so poorly treated by the current crop of drugs that new medicines have big sales ...
Lifestyle changes like reducing caffeine and managing fluid intake are recommended before using medications for overactive ...